| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 72.15B | 69.23B | 65.45B | 58.76B | 52.15B | 49.91B |
| Gross Profit | 11.21B | 10.68B | 10.04B | 10.57B | 9.63B | 5.66B |
| EBITDA | 10.29B | 9.18B | 7.77B | 8.20B | 7.71B | 2.07B |
| Net Income | 5.07B | 4.23B | 3.79B | 4.25B | 4.21B | -1.17B |
Balance Sheet | ||||||
| Total Assets | 129.67B | 129.21B | 118.87B | 115.94B | 107.05B | 110.09B |
| Cash, Cash Equivalents and Short-Term Investments | 11.26B | 19.18B | 18.83B | 18.25B | 16.43B | 16.52B |
| Total Debt | 13.52B | 11.28B | 13.59B | 10.98B | 13.46B | 15.62B |
| Total Liabilities | 102.33B | 109.52B | 101.14B | 102.96B | 97.56B | 103.64B |
| Stockholders Equity | 27.25B | 19.61B | 17.70B | 12.95B | 9.47B | 6.45B |
Cash Flow | ||||||
| Free Cash Flow | 3.57B | 3.73B | 3.20B | 3.82B | 2.71B | -7.18B |
| Operating Cash Flow | 7.42B | 7.40B | 6.25B | 6.29B | 4.64B | -5.42B |
| Investing Cash Flow | -4.65B | -6.65B | -4.13B | -3.11B | -2.72B | 4.13B |
| Financing Cash Flow | -3.27B | -2.57B | -1.28B | -2.12B | -2.18B | 6.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $98.86B | 23.72 | 17.78% | 1.73% | 11.86% | 17.39% | |
77 Outperform | $336.36B | 42.52 | 42.74% | 0.48% | -19.21% | 31.83% | |
74 Outperform | $266.60B | 40.83 | 10.49% | 1.44% | 8.79% | 39.63% | |
70 Outperform | $132.52B | 31.97 | 62.78% | 2.77% | 2.88% | -35.15% | |
66 Neutral | $197.92B | 35.71 | 22.66% | 1.47% | 9.15% | 56.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | $189.98B | -18.10 | ― | ― | 10.19% | -6.03% |